OpenVSafe by OpenVAERS
Search V-safe

8RV-29124-42792

2 vaccinations 11 coded responses 25 check-ins 11 free-text entries 9 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
956 / CA
Registered
2020-12-30
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-30
    Registered in v-safe
  2. 2020-12-30
    Dose 1 — Moderna
  3. 2020-12-30
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain · None
    Adult check-in
  4. 2020-12-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · None
    Adult check-in
  6. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Nausea
    Adult check-in
  10. 2021-01-06
    Health check-in — day 7, dose 1
    Feeling: Fair · None
    Adult check-in
  11. 2021-01-13
    Survey response — day 14, dose 1
    MedDRA: Aphonia, Injection site rash — Feeling: Fair
    Free text: I lost my voice, and 8 days after my vaccine, I developed a rash at the injection site.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-20
    Survey response — day 21, dose 1
    MedDRA: Chest discomfort, Chest pain — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: I have had chest pain and tightness.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-01-20
    Report sent to call center — day 21, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  14. 2021-01-27
    Survey response — day 28, dose 1
    MedDRA: Cardiac disorder — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: I have developed what is believed to be some sort of heart issue.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-01-27
    Report sent to call center — day 28, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  16. 2021-01-28
    Dose 2 — Moderna
  17. 2021-01-28
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · None
    Adult check-in
  18. 2021-01-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  19. 2021-01-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  20. 2021-01-31
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work
    Adult check-in
  21. 2021-02-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chest pain, Dyspnoea, Heart rate increased — Feeling: Poor · Site: Itching · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Ongoing chest pain, elevated heart rate and shortness of breath; since 2 weeks after my first dose.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-02-01
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  23. 2021-02-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chest discomfort, Chest pain, Dyspnoea — Feeling: Fair · Site: Itching · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Ongoing chest pain, tightness and difficulty breathing since 2 weeks after 1st dose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-02-02
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-02-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chest discomfort, Chest pain, Dyspnoea — Feeling: Fair · Site: Itching · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Chest pain, chest tightness and shortness of breath since 2 weeks after 1st dose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-02-03
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  27. 2021-02-04
    Survey response — day 7, dose 2
    MedDRA: Chest discomfort, Chest pain, Dyspnoea — Feeling: Fair · Site: Itching · Muscle or body aches · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Chest pain, tightness and difficulty breathing since 2 weeks after 1st dose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  28. 2021-02-04
    Report sent to call center — day 7, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  29. 2021-02-11
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  30. 2021-02-18
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  31. 2021-02-25
    Survey response — day 28, dose 2
    MedDRA: Chest discomfort, Chest pain, Dyspnoea, Heart rate increased — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Chest pain, tightness, shortness of breath, and elevated heart rate
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  32. 2021-02-25
    Report sent to call center — day 28, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  33. 2021-03-04
    Survey response — day 35, dose 2
    MedDRA: Chest pain, Dyspnoea, Fatigue, Heart rate increased — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Chest pain, elevated heart rate, difficulty breathing and exhaustion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  34. 2021-03-04
    Report sent to call center — day 35, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  35. 2021-03-11
    Survey response — day 42, dose 2
    MedDRA: Chest discomfort, Chest pain, Confusional state, Dyspnoea, Heart rate increased, Pruritus — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Shortness of breath, elevated heart rate, chest pain and tightness, confusion, and itching
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  36. 2021-03-11
    Report sent to call center — day 42, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  37. 2021-03-25
  38. 2021-05-01
    Survey response — 3 months, dose 2
    MedDRA: Vision blurred — Feeling: Fair · Be unable to work
    Free text: Blurred vision, primarily when looking at computer or TV Screens.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-30Moderna
22021-01-28Moderna

Call center

9 call center cases

9 unsuccessful

See the call center timeline

Free text

Release 1 — day 14, dose 1

2021-01-13

Symptoms: I lost my voice, and 8 days after my vaccine, I developed a rash at the injection site.

Release 2 — day 21, dose 1

2021-01-20

Symptoms: I have had chest pain and tightness.

Release 2 — day 28, dose 1

2021-01-27

Symptoms: I have developed what is believed to be some sort of heart issue.

Release 3 — days 1–6 daily, dose 2

2021-02-01

Systemic reaction (other): Ongoing chest pain, elevated heart rate and shortness of breath; since 2 weeks after my first dose.

2021-02-02

Systemic reaction (other): Ongoing chest pain, tightness and difficulty breathing since 2 weeks after 1st dose

2021-02-03

Systemic reaction (other): Chest pain, chest tightness and shortness of breath since 2 weeks after 1st dose

Release 3 — day 7, dose 2

2021-02-04

Systemic reaction (other): Chest pain, tightness and difficulty breathing since 2 weeks after 1st dose

Release 4 — day 28, dose 2

2021-02-25

Symptoms: Chest pain, tightness, shortness of breath, and elevated heart rate

Release 5 — day 35, dose 2

2021-03-04

Symptoms: Chest pain, elevated heart rate, difficulty breathing and exhaustion

Release 5 — day 42, dose 2

2021-03-11

Symptoms: Shortness of breath, elevated heart rate, chest pain and tightness, confusion, and itching

Release 8 — 3 months, dose 2

2021-05-01

Symptoms: Blurred vision, primarily when looking at computer or TV Screens.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAphonia ✓ ✓ ✓
SDCardiac disorder ✓ ✓ ✓
SDChest discomfort ✓ ✓ ✓
SDChest pain ✓ ✓ ✓
SDConfusional state ✓ ✓ ✓
SDDyspnoea ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeart rate increased ✓ ✓ ✓
SDInjection site rash ✓ ✓ ✓
SDPruritus ✓ ✓ ✓
SDVision blurred ✓ ✓ ✓
SROChest discomfort ✓ ✓ ✓
SROChest pain ✓ ✓ ✓
SRODyspnoea ✓ ✓ ✓
SROHeart rate increased ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release